Canada Pharmaceuticals

HLS Therapeutics Inc (HLS)

Track

Over the past 90 days, HLS Therapeutics Inc. recorded two insider transactions, both representing open-market purchases by executives totaling approximately $18,611. These acquisitions occurred following the company's May 2026 earnings report, where it beat EPS expectations by 41.7%. The stock has experienced a 10.8% decline over the last three months.
Ticker: HLS Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for HLS Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.8
Millian, Craig Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
120.58
Quantity 18,720 +17.2%
Value US$3,703,624
2.5
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
346.04
Quantity 85,477 +44.2%
Value CA$580,531
2.4
Edinboro, Dawn Senior Officer of Issuer Officer
Transaction date
Purchase
Price
378.11
Quantity 61,810 +38.8%
Value CA$1,484,697
2.4
Edinboro, Dawn Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.97
Quantity 600
Value CA$2,982
3.6
Welborn, Jr., John Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
3.93
Quantity 42,184 +42.6%
Value CA$165,783
1.5
Beauchamp, Norma Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
3.91
Quantity 500
Value CA$1,957
3.6
Welborn, Jr., John Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
3.25
Quantity 2,100 +2.2%
Value CA$6,825
1.5
Beauchamp, Norma Director of Issuer Non-Executive Director
Transaction date
Sale
Price
3.31
Quantity 500
Value CA$1,655
2.5
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
3.19
Quantity 1,200 +17.6%
Value CA$3,828
2.5
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
3.19
Quantity 2,800 +70.0%
Value CA$8,932
0.8
Millian, Craig Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
2.90
Quantity 2,500 +25.0%
Value US$7,250
1.5
Walsh, Brian Thomas Senior Officer of Issuer Officer
Transaction date
Purchase
Price
2.91
Quantity 1,000 +500.0%
Value US$2,910
1.5
Walsh, Brian Thomas Senior Officer of Issuer Officer
Transaction date
Purchase
Price
2.92
Quantity 200
Value US$584
1.4
Polar Asset Management Partners Inc. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
3.70
Quantity 2,400 +0.0%
Value CA$8,877
1.4
Polar Asset Management Partners Inc. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
4.30
Quantity 20,000
Value CA$86,000
1.4
Polar Asset Management Partners Inc. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
4.36
Quantity 10,000 +0.2%
Value CA$43,600
2.5
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
4.50
Quantity 4,000
Value CA$18,000
2.2
Athyrium Opportunities II Co-Invest 1 LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
5.78
Quantity 1,300,000 -29.9%
Value CA$7,507,500
3.6
Welborn, Jr., John Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
4.30
Quantity 97,000
Value CA$417,100
3.4
Hendrickson, Tim Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.50
Quantity 2,500 +3.8%
Value CA$11,250
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-17 B Purchase
0.8
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
18,720 +17.2%
120.58
US$3,703,624 		18,720 +17.2% 120.58 US$3,703,624
2026-06-17 2026-06-16 B Purchase
2.5
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
85,477 +44.2%
346.04
CA$580,531 		85,477 +44.2% 346.04 CA$580,531
2025-06-19 2025-06-18 B Purchase
2.4
Edinboro, Dawn

Senior Officer of Issuer

Officer
61,810 +38.8%
378.11
CA$1,484,697 		61,810 +38.8% 378.11 CA$1,484,697
2025-06-19 2025-06-18 B Purchase
2.4
Edinboro, Dawn

Senior Officer of Issuer

Officer
600
4.97
CA$2,982 		600 4.97 CA$2,982
2025-01-08 2024-12-31 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
42,184 +42.6%
3.93
CA$165,783 		42,184 +42.6% 3.93 CA$165,783
2024-12-27 2024-12-24 B Purchase
1.5
Beauchamp, Norma

Director of Issuer

Non-Executive Director
500
3.91
CA$1,957 		500 3.91 CA$1,957
2024-12-16 2024-12-12 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
2,100 +2.2%
3.25
CA$6,825 		2,100 +2.2% 3.25 CA$6,825
2024-11-14 2024-11-14 S Sale
1.5
Beauchamp, Norma

Director of Issuer

Non-Executive Director
500
3.31
CA$1,655 		500 3.31 CA$1,655
2024-08-14 2024-08-14 B Purchase
2.5
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
1,200 +17.6%
3.19
CA$3,828 		1,200 +17.6% 3.19 CA$3,828
2024-08-14 2024-08-13 B Purchase
2.5
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
2,800 +70.0%
3.19
CA$8,932 		2,800 +70.0% 3.19 CA$8,932
2024-05-16 2024-05-15 B Purchase
0.8
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
2,500 +25.0%
2.90
US$7,250 		2,500 +25.0% 2.90 US$7,250
2023-11-15 2023-11-15 B Purchase
1.5
Walsh, Brian Thomas

Senior Officer of Issuer

Officer
1,000 +500.0%
2.91
US$2,910 		1,000 +500.0% 2.91 US$2,910
2023-11-15 2023-11-13 B Purchase
1.5
Walsh, Brian Thomas

Senior Officer of Issuer

Officer
200
2.92
US$584 		200 2.92 US$584
2023-11-14 2023-11-10 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
2,400 +0.0%
3.70
CA$8,877 		2,400 +0.0% 3.70 CA$8,877
2023-11-14 2023-11-10 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
20,000
4.30
CA$86,000 		20,000 4.30 CA$86,000
2023-11-14 2023-11-09 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
10,000 +0.2%
4.36
CA$43,600 		10,000 +0.2% 4.36 CA$43,600
2023-08-29 2023-08-25 B Purchase
2.5
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
4,000
4.50
CA$18,000 		4,000 4.50 CA$18,000
2023-07-04 2023-06-30 S Sale
2.2
Athyrium Opportunities II Co-Invest 1 LP

10% Security Holder of Issuer

Large shareholder
1,300,000 -29.9%
5.78
CA$7,507,500 		1,300,000 -29.9% 5.78 CA$7,507,500
2023-06-12 2023-06-08 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
97,000
4.30
CA$417,100 		97,000 4.30 CA$417,100
2023-05-23 2023-05-19 B Purchase
3.4
Hendrickson, Tim

Senior Officer of Issuer

Officer
2,500 +3.8%
4.50
CA$11,250 		2,500 +3.8% 4.50 CA$11,250
Explore more

More insider trading research around HLS Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America